Fridman WH - Search Results

1

Trial Watch: Monoclonal antibodies in cancer therapy.

Galluzzi L, Vacchelli E, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zucman-Rossi J, Zitvogel L, Kroemer G. Galluzzi L, et al. Among authors: fridman wh. Oncoimmunology. 2012 Jan 1;1(1):28-37. doi: 10.4161/onci.1.1.17938. Oncoimmunology. 2012. PMID: 22720209 Free PMC article.

2

Murine soluble Fc gamma receptors/IgG-binding factors (IgG-BF): analysis of the relation to Fc gamma RII and production of milligram quantities of biologically active recombinant IgG-BF.

Sautès C, Mazières N, Galinha A, Tartour E, Bonnerot C, Amigorena S, Teillaud C, Spagnoli R, Fridman WH. Sautès C, et al. Among authors: fridman wh. Immunol Res. 1992;11(3-4):181-90. doi: 10.1007/BF02919125. Immunol Res. 1992. PMID: 1287114 Review.

3

Current status of interleukin-2 therapy in cancer.

Tartour E, Mathiot C, Fridman WH. Tartour E, et al. Among authors: fridman wh. Biomed Pharmacother. 1992;46(10):473-84. doi: 10.1016/0753-3322(92)90005-r. Biomed Pharmacother. 1992. PMID: 1306361 Review.

4

Soluble Fc gamma R (sFc gamma R): detection in biological fluids and production of a murine recombinant sFc gamma R biologically active in vitro and in vivo.

Sautès C, Teillaud C, Mazières N, Tartour E, Bouchard C, Galinha A, Jourde M, Spagnoli R, Fridman WH. Sautès C, et al. Among authors: fridman wh. Immunobiology. 1992 Aug;185(2-4):207-21. doi: 10.1016/s0171-2985(11)80642-x. Immunobiology. 1992. PMID: 1452202 Review.

5

Increased levels of soluble low-affinity Fc gamma receptors (IgG-binding factors) in the sera of tumour-bearing mice.

Lynch A, Tartour E, Teillaud JL, Asselain B, Fridman WH, Sautès C. Lynch A, et al. Among authors: fridman wh. Clin Exp Immunol. 1992 Feb;87(2):208-14. doi: 10.1111/j.1365-2249.1992.tb02976.x. Clin Exp Immunol. 1992. PMID: 1531189 Free PMC article.

6

A transforming growth factor beta-like immunosuppressive factor in immunoglobulin G-binding factor.

Bouchard C, Galinha A, Tartour E, Fridman WH, Sautès C. Bouchard C, et al. Among authors: fridman wh. J Exp Med. 1995 Dec 1;182(6):1717-26. doi: 10.1084/jem.182.6.1717. J Exp Med. 1995. PMID: 7500016 Free PMC article.

7

[Immunotherapy of malignant diseases].

Dorval T, Michon J, Tartour E, Fridman WH. Dorval T, et al. Among authors: fridman wh. Bull Cancer. 1995;82 Suppl 2:127s-138s. Bull Cancer. 1995. PMID: 7542946 Review. French.

8

Lack of efficacy of low-dose subcutaneous recombinant interleukin-2 and interferon-alpha in the treatment of metastatic renal cell carcinoma.

Thiounn N, Mathiot C, Dorval T, Flam TA, Tartour E, Mosseri V, Zerbib M, Fridman WH, Debre B. Thiounn N, et al. Among authors: fridman wh. Br J Urol. 1995 May;75(5):586-9. doi: 10.1111/j.1464-410x.1995.tb07412.x. Br J Urol. 1995. PMID: 7613793

9

[Role of cell therapy in the management of cancer].

Fridman WH, Mathiot C, Tartour E, Dorval T, Thiounn N, Pouillart P, Debre B. Fridman WH, et al. Bull Cancer. 1995 Mar;82(3):235-6. Bull Cancer. 1995. PMID: 7655161 French. No abstract available.

10

[Endocrine involvement in immunotherapy].

Tartour E, Schlumberger M, Dorval T, Baudin E, Fridman WH. Tartour E, et al. Among authors: fridman wh. Ann Endocrinol (Paris). 1995;56(2):143-8. Ann Endocrinol (Paris). 1995. PMID: 7755342 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters